157 related articles for article (PubMed ID: 6981469)
1. Vitamin D metabolism in hyperthyroidism.
MacFarlane IA; Mawer EB; Berry J; Hann J
Clin Endocrinol (Oxf); 1982 Jul; 17(1):51-9. PubMed ID: 6981469
[TBL] [Abstract][Full Text] [Related]
2. Elevated metabolic clearance rate of 1 alpha,25-dihydroxyvitamin D3 in hyperthyroidism.
Karsenty G; Bouchard P; Ulmann A; Schaison G
Acta Endocrinol (Copenh); 1985 Sep; 110(1):70-4. PubMed ID: 3839963
[TBL] [Abstract][Full Text] [Related]
3. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats.
Matsumoto T; Ikeda K; Yamato H; Morita K; Ezawa I; Fukushima M; Nishii Y; Ogata E
Biochem J; 1988 Mar; 250(3):671-7. PubMed ID: 2839142
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
Tenenhouse HS; Jones G
Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
[TBL] [Abstract][Full Text] [Related]
6. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E
Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
Kubota M; Ohno J; Shiina Y; Suda T
Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
[TBL] [Abstract][Full Text] [Related]
8. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
Bikle DD; Rasmussen H
J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
10. The relationship between bone apposition rate and vitamin D activity in phosphate-deficient rats.
Harrison JE; Tam CS; Hitchman AJ; Hitchman A; Hasany SA; Jones G
Metabolism; 1986 Feb; 35(2):126-9. PubMed ID: 3484801
[TBL] [Abstract][Full Text] [Related]
11. Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism.
Mosekilde L; Charles P; Lindegreen P
Bone Miner; 1989 Mar; 5(3):279-90. PubMed ID: 2720198
[TBL] [Abstract][Full Text] [Related]
12. Influence of cadmium on the metabolism of vitamin D3 in rats.
Ando M; Shimizu M; Matsui S; Sayato Y; Takeda M
Toxicol Appl Pharmacol; 1987 Jun; 89(2):158-64. PubMed ID: 3037727
[TBL] [Abstract][Full Text] [Related]
13. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
[TBL] [Abstract][Full Text] [Related]
14. The effect of vitamin D on bone in vivo.
Tam CS; Heersche JN; Jones G; Murray TM; Rasmussen H
Endocrinology; 1986 Jun; 118(6):2217-24. PubMed ID: 3486118
[TBL] [Abstract][Full Text] [Related]
15. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
17. The metabolism of a physiological dose of radioactive cholecalciferol (vitamin D3) to its hydroxylated metabolites in man.
Stanbury SW; Mawer EB
Clin Sci (Lond); 1980 Jun; 58(6):523-35. PubMed ID: 6253118
[TBL] [Abstract][Full Text] [Related]
18. Serum and bone vitamin D metabolites in elective patients and patients after fracture.
Alkalay D; Shany S; Dekel S
J Bone Joint Surg Br; 1989 Jan; 71(1):85-7. PubMed ID: 2783695
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
20. Abnormal vitamin D metabolism in Paget's disease of bone.
Guillard-Cumming DF; Beard DJ; Douglas DL; Johnson SK; Lawson-Matthew PJ; Russell RG; Kanis JA
Clin Endocrinol (Oxf); 1985 Apr; 22(4):559-66. PubMed ID: 3872746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
